Mediterranean spotted fever in a patient with Crohn's disease under adalimumab: First case report and review of the literature

Gastroenterol Hepatol. 2015 Jun-Jul;38(6):379-80. doi: 10.1016/j.gastrohep.2014.05.013. Epub 2014 Jul 26.

Authors

João Santos-Antunes¹, Amadeu C R Nunes², Guilherme Macedo²

Affiliations

¹ Gastroenterology Department, Faculty of Medicine, Hospital de São João, Porto, Portugal; Department of Biochemistry (U38-FCT), Faculty of Medicine, University of Porto, Portugal. Electronic address: joao.claudio.antunes@gmail.com.
² Gastroenterology Department, Faculty of Medicine, Hospital de São João, Porto, Portugal.

PMID: 25073681
DOI: 10.1016/j.gastrohep.2014.05.013

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adalimumab / adverse effects*
Adalimumab / therapeutic use
Animals
Anti-Bacterial Agents / therapeutic use
Anti-Inflammatory Agents / adverse effects*
Anti-Inflammatory Agents / therapeutic use
Boutonneuse Fever / complications*
Boutonneuse Fever / transmission
Crohn Disease / complications
Crohn Disease / drug therapy*
Doxycycline / therapeutic use
Environmental Exposure
Humans
Immunocompromised Host
Male
Middle Aged
Spondylitis, Ankylosing / complications
Spondylitis, Ankylosing / drug therapy*
Tick Bites / complications
Tick Bites / microbiology
Wound Infection / etiology
Zoonoses

Substances

Anti-Bacterial Agents
Anti-Inflammatory Agents
Adalimumab
Doxycycline